Sharps Technology, Inc. (STSS)
NASDAQ: STSS · Real-Time Price · USD
0.0292
-0.0016 (-5.19%)
At close: Apr 23, 2025, 4:00 PM
0.0290
-0.0002 (-0.68%)
After-hours: Apr 23, 2025, 7:47 PM EDT

Company Description

Sharps Technology, Inc., a medical device company, engages in the design, research and development, manufacturing, and commercialization of safety syringe products in the United States.

The company provides safety syringe products comprising Securgard, Sologard, and Sharps Provensa that are ultra-low waste syringes for passive, and safety and reuse prevention features, as well as develops prefillable syringe systems.

Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Sharps Technology, Inc.
Sharps Technology logo
Country United States
Founded 2017
IPO Date Apr 14, 2022
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 55
CEO Robert Hayes

Contact Details

Address:
105 Maxess Road, Suite 124
Melville, New York 11747
United States
Phone 631 574 4436
Website sharpstechnology.com

Stock Details

Ticker Symbol STSS
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $4.25
CIK Code 0001737995
CUSIP Number 82003F101
ISIN Number US82003F1012
Employer ID 82-3751728
SIC Code 3841

Key Executives

Name Position
Robert M. Hayes Chief Executive Officer and Director
Andrew R. Crescenzo CPA Chief Financial Officer
Ben Scheu Senior Director of Sales
Frank Parrado Corporate Controller

Latest SEC Filings

Date Type Title
Apr 18, 2025 8-K Current Report
Apr 15, 2025 10-K/A [Amend] Annual report
Apr 14, 2025 8-K Current Report
Apr 4, 2025 8-K Current Report
Apr 3, 2025 8-K Current Report
Apr 2, 2025 8-K Current Report
Mar 28, 2025 8-K Current Report
Mar 27, 2025 10-K Annual Report
Mar 20, 2025 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 20, 2025 8-K Current Report